Engineering Inflammation‐Resistant Cartilage: Bridging Gene Therapy and Tissue Engineering
Open Access
- 15 March 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (17) , e2202271
Abstract
Articular cartilage defects caused by traumatic injury rarely heal spontaneously and predispose into post‐traumatic osteoarthritis. In the current autologous cell‐based treatments the regenerative process is often hampered by the poor regenerative capacity of adult cells and the inflammatory state of the injured joint. The lack of ideal treatment options for cartilage injuries motivated the authors to tissue engineer a cartilage tissue which would be more resistant to inflammation. A clustered regularly interspaced short palindromic repeats (CRISPR)‐Cas9 knockout of TGF‐β‐activated kinase 1 (TAK1) gene in polydactyly chondrocytes provides multivalent protection against the signals that activate the pro‐inflammatory and catabolic NF‐κB pathway. The TAK1‐KO chondrocytes encapsulate into a hyaluronan hydrogel deposit copious cartilage extracellular matrix proteins and facilitate integration onto native cartilage, even under proinflammatory conditions. Furthermore, when implanted in vivo, compared to WT fewer pro‐inflammatory M1 macrophages invade the cartilage, likely due to the lower levels of cytokines secreted by the TAK1‐KO polydactyly chondrocytes. The engineered cartilage thus represents a new paradigm‐shift for the creation of more potent and functional tissues for use in regenerative medicine.Keywords
Funding Information
- Suomen Kulttuurirahasto (00220103)
This publication has 91 references indexed in Scilit:
- Improved cartilage repair viain vitropre-maturation of MSC-seeded hyaluronic acid hydrogelsBiomedical Materials, 2012
- Integration of Tissue-engineered Cartilage With Host Cartilage: An In Vitro ModelClinical Orthopaedics and Related Research, 2011
- TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathwaysJournal of Bone and Mineral Research, 2010
- Chondrocyte innate immune myeloid differentiation factor 88–dependent signaling drives procatabolic effects of the endogenous toll‐like receptor 2/toll‐like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in miceArthritis & Rheumatism, 2010
- Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentagesArthritis Research & Therapy, 2010
- ERK1/2 Activation Induced by Inflammatory Cytokines Compromises Effective Host Tissue Integration of Engineered CartilageTissue Engineering Part A, 2009
- TAK1 is an essential regulator of BMP signalling in cartilageThe EMBO Journal, 2009
- TAK1 represses transcription of the human telomerase reverse transcriptase geneOncogene, 2007
- TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB PathwayJournal of Molecular Biology, 2003
- Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell cultureOsteoarthritis and Cartilage, 2002